When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

HIV infection in pregnancy

Última revisão: 16 Aug 2025
Última atualização: 05 Feb 2025

Resumo

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • increased risk of maternal HIV infection
  • increased risk of perinatal HIV transmission
Todos los datos

Otros factores de diagnóstico

  • oral candidiasis
  • increasing dyspnea
  • weight loss
  • fever
  • malaise
  • lymphadenopathy
  • maculopapular blanching rash
Todos los datos

Factores de riesgo

  • needle-sharing with injection drug use
  • unprotected receptive penile-vaginal intercourse
  • unprotected receptive anal intercourse
  • percutaneous needle stick
  • sexually transmitted infections (STIs) and bacterial vaginosis
  • high maternal viral load (perinatal transmission)
  • absence of prenatal maternal antiretroviral therapy (perinatal transmission)
  • breast-feeding in mothers without viral suppression (perinatal transmission)
  • violence against women and girls
  • receptive oral intercourse
  • insertive oral intercourse
  • multiple sexual partners
  • low maternal CD4 count (perinatal transmission)
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • maternal HIV-1/HIV-2 antigen/antibody enzyme-linked immunosorbent assay (ELISA)
  • maternal HIV-1/HIV-2 antibody differentiation immunoassay
  • neonatal HIV DNA or RNA polymerase chain reaction (PCR)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • HIV-1 western blot
  • HIV-1 indirect immunofluorescence assay (IFA)
  • HIV-1 nucleic acid test (NAT)
  • CD4 count
  • plasma HIV RNA levels (viral load)
  • renal function tests
  • liver function tests (LFTs)
  • drug resistance tests
  • complete blood count
  • glucose screening
  • fetal ultrasound
  • tests for coinfections
Todos los datos

Algoritmo de tratamiento

Agudo

HIV-1-infected pregnant women: <38 weeks not in labor (regardless of HIV RNA level)

HIV-1-infected pregnant women with HIV-1 RNA levels >1000 copies/mL: at 38 weeks or in labor

HIV-1-infected pregnant women with HIV-1 RNA levels ≤1000 copies/mL: at 38 weeks or in labor

infants born to HIV-infected mothers

Colaboradores

Autores

Rachel K. Scott, MD, MPH, FACOG

Associate Professor of Obstetrics and Gynecology

Georgetown University School of Medicine

Scientific Director of Women’s Health Research

MedStar Health Research Institute

Associate Chair for Research

MedStar Washington Hospital Center Department of Women’s and Infants’ Services

Washington

DC

Divulgaciones

RKS declares that she has participated in an advisory meeting for ViiV Healthcare and has received research funding from ViiV, managed by MedStar Health Institute.

Agradecimientos

Dr Rachel K. Scott would like to gratefully acknowledge Dr Isaac Delke, Dr Christina Bailey, and Dr Mettassebia Kano, the previous contributors to this topic.

Divulgaciones

ID, CB, and MK declare that they have no competing interests.

Revisores por pares

Aisha Sethi, MD

Assistant Professor of Medicine

Associate Residency Program Director

University of Chicago

Chicago

IL

Divulgaciones

AS declares that she has no competing interests.

Graham P. Taylor, MBChB, FRCP, FHEA

Reader in Communicable Diseases

Faculty of Medicine

Imperial College

London

UK

Divulgaciones

GPT has been reimbursed by various pharmaceutical companies for attending conferences, lecturing, and consulting, and has been chief investigator of investigator-initiated industry-funded research on HIV and pregnancy.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States. Jan 2024 [internet publication].Texto completo

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diagnósticos diferenciais

    • Infectious mononucleosis
    • Toxoplasmosis
    • Viral hepatitis
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States
    • Care of pregnant women living with HIV and interventions to reduce perinatal transmission
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    HIV infection in pregnancy

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal